Literature DB >> 8568533

Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis.

L Mazzini1, T Corrà, M Zaccala, G Mora, M Del Piano, M Galante.   

Abstract

Bulbar involvement in amyotrophic lateral sclerosis (ALS) is often related to a worse prognosis on account of the higher risk of pulmonary aspiration and undernutrition due to dysphagia. The aim of our study was to assess the effects of enteral feeding by percutaneous endoscopic gastrostomy (PEG) in a long-term follow-up of ALS patients. We report the results of PEG in 31 ALS patients with bulbar involvement. The patients were observed at 3-monthly intervals over a period of 2 years after PEG. All the data were compared with those obtained from a control group of 35 ALS patients who refused PEG. Mortality did not differ significantly between the two groups of patients during the first 6 months of observation, whereas after this period it was lower in the PEG group. In the patients who had had PEG, the body mass index showed a mild but statistically significant improvement after tube insertion while in the control group it decreased significantly. The findings of this study demonstrate that PEG can improve survival in elderly and young ALS patients with bulbar involvement; it enhances their quality of life and helps their integration in their social and family surroundings. We think that PEG should be included symptomatic treatment of all ALS patients with bulbar involvement from the onset of symptoms.

Entities:  

Mesh:

Year:  1995        PMID: 8568533     DOI: 10.1007/bf00866922

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  15 in total

Review 1.  Percutaneous endoscopic gastrostomy: indications, limitations, techniques, and results.

Authors:  J L Ponsky; M W Gauderer
Journal:  World J Surg       Date:  1989 Mar-Apr       Impact factor: 3.352

2.  Obese, overweight, desirable, ideal: where to draw the line in 1986?

Authors:  L O Schulz
Journal:  J Am Diet Assoc       Date:  1986-12

3.  The administration of guanidine in amyotrophic lateral sclerosis.

Authors:  F H Norris; P R Calanchini; R J Fallat; S Panchari; B Jewett
Journal:  Neurology       Date:  1974-08       Impact factor: 9.910

4.  El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors.

Authors:  B R Brooks
Journal:  J Neurol Sci       Date:  1994-07       Impact factor: 3.181

Review 5.  Motor neuron disease.

Authors:  P N Leigh; K Ray-Chaudhuri
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-08       Impact factor: 10.154

6.  Metabolic and structural changes in skeletal muscle during hypocaloric dieting.

Authors:  D M Russell; P M Walker; L A Leiter; A A Sima; W K Tanner; D A Mickle; J Whitwell; E B Marliss; K N Jeejeebhoy
Journal:  Am J Clin Nutr       Date:  1984-04       Impact factor: 7.045

7.  Assessment of the percutaneous endoscopic gastrostomy feeding tube as part of an integrated approach to enteral feeding.

Authors:  C Wicks; A Gimson; P Vlavianos; M Lombard; M Panos; P Macmathuna; M Tudor; K Andrews; D Westaby
Journal:  Gut       Date:  1992-05       Impact factor: 23.059

8.  Onset, natural history and outcome in idiopathic adult motor neuron disease.

Authors:  F Norris; R Shepherd; E Denys; K U; E Mukai; L Elias; D Holden; H Norris
Journal:  J Neurol Sci       Date:  1993-08       Impact factor: 3.181

9.  Motor neurone disease: towards better care.

Authors:  F H Norris; R A Smith; E H Denys
Journal:  Br Med J (Clin Res Ed)       Date:  1985-07-27

10.  Duration of amyotrophic lateral sclerosis is age dependent.

Authors:  A Eisen; M Schulzer; M MacNeil; B Pant; E Mak
Journal:  Muscle Nerve       Date:  1993-01       Impact factor: 3.217

View more
  43 in total

1.  Amyotrophic Lateral Sclerosis.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-01       Impact factor: 3.598

Review 2.  The management of motor neurone disease.

Authors:  P N Leigh; S Abrahams; A Al-Chalabi; M-A Ampong; L H Goldstein; J Johnson; R Lyall; J Moxham; N Mustfa; A Rio; C Shaw; E Willey
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-12       Impact factor: 10.154

Review 3.  Management of motor neurone disease.

Authors:  R S Howard; R W Orrell
Journal:  Postgrad Med J       Date:  2002-12       Impact factor: 2.401

Review 4.  Complementary and Alternative Therapies in Amyotrophic Lateral Sclerosis.

Authors:  Richard S Bedlack; Nanette Joyce; Gregory T Carter; Sabrina Paganoni; Chafic Karam
Journal:  Neurol Clin       Date:  2015-09-08       Impact factor: 3.806

Review 5.  Percutaneous endoscopic gastrostomy: a safe and effective bridge for enteral nutrition in neurological or non-neurological conditions.

Authors:  Rasim Gencosmanoglu
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

6.  Amyotrophic lateral sclerosis: clinical management and research update.

Authors:  Jinsy Andrews
Journal:  Curr Neurol Neurosci Rep       Date:  2009-01       Impact factor: 5.081

Review 7.  ALS drug development: reflections from the past and a way forward.

Authors:  Swati Aggarwal; Merit Cudkowicz
Journal:  Neurotherapeutics       Date:  2008-10       Impact factor: 7.620

Review 8.  Diagnostic investigation and multidisciplinary management in motor neuron disease.

Authors:  J A Rocha; C Reis; F Simões; J Fonseca; J Mendes Ribeiro
Journal:  J Neurol       Date:  2005-12       Impact factor: 4.849

9.  Estimating daily energy expenditure in individuals with amyotrophic lateral sclerosis.

Authors:  Edward J Kasarskis; Marta S Mendiondo; Dwight E Matthews; Hiroshi Mitsumoto; Rup Tandan; Zachary Simmons; Mark B Bromberg; Richard J Kryscio
Journal:  Am J Clin Nutr       Date:  2014-02-12       Impact factor: 7.045

10.  Frequency, timing and outcome of gastrostomy tubes for amyotrophic lateral sclerosis/motor neurone disease--a record linkage study from the Scottish Motor Neurone Disease Register.

Authors:  Raeburn B Forbes; Shuna Colville; Robert J Swingler
Journal:  J Neurol       Date:  2004-07       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.